









Markets
/
Stocks
/
nasdaq-beat
/

Heartbeam Inc

BEAT

1.690USD

+0.100+6.29%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

57.49MMarket Cap

LossP/E TTM



Heartbeam Inc

1.690

+0.100+6.29%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

140 / 207

Overall Ranking

375 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

4.500

Target Price

+183.02%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 50.04.

Fairly Valued

The company’s latest PE is -2.43, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 11.32M shares, decreasing 0.14% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.12M shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

There is no financial score for this company; the Healthcare Equipment & Supplies industry's average is 7.32.

Score

Industry at a Glance

Previous score

0.00

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -2.29, which is -15.09% below the recent high of -1.94 and -40.40% above the recent low of -3.21.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 140/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Heartbeam Inc is 4.50, with a high of 8.00 and a low of 1.00.

Score

Industry at a Glance

Previous score

7.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

4.500

Target Price

+166.27%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Heartbeam Inc

BEAT

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 8.81, which is higher than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.79 and the support level at 1.23, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.81

Change

0.11

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

0.055

Buy

RSI(14)

73.062

Buy

STOCH(KDJ)(9,3,3)

78.258

Buy

ATR(14)

0.126

Low Volatility

CCI(14)

264.205

Overbought

Williams %R

16.501

Overbought

TRIX(12,20)

1.115

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

1.512

Buy

MA10

1.445

Buy

MA20

1.362

Buy

MA50

1.236

Buy

MA100

1.409

Buy

MA200

1.795

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 33.48%, representing a quarter-over-quarter increase of 0.02%. The largest institutional shareholder is The Vanguard, holding a total of 1.12M shares, representing 3.26% of shares outstanding, with 13.81% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Strome Mezzanine Fund, L.P.

3.15M

Schwartzberg (Andrew)

1.90M

The Vanguard Group, Inc.

Star Investors

823.01K

+7.77%

Public Ventures LLC

1.07M

+0.37%

Vajdic (Branislav)

911.39K

+0.14%

Elfrink (Willhem P.)

424.81K

Smith, Salley & Associates, LLC

367.65K

+47.06%

Geode Capital Management, L.L.C.

247.37K

+2.29%

Beacon Pointe Advisors LLC

100.00K

-25.00%

Ferrari (Richard M)

244.79K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.08, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is -0.70. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.